Sam Tsimikas, University of California, San Diego, and Ionis Pharmaceuticals, USA, presents data on the effects of olezarsen on triglycerides and acute pancreatitis, and updates on the Bridge-TMI 73a, Essence, CORE and CORE2 studies.
Please login or create a FREE account to view this content